FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003180819> ?p ?o ?g. }

• W2003180819 abstract "The chromosomes of 111 ovarian cancer patients were studied in G- and C-banded slides from peripheral blood lymphocyte (PBL) cultures for chromosome damage caused by chemotherapy and radiotherapy and for asymmetry of the constitutive heterochromatin of chromosomes 1, 9, and 16. We also monitored the survival of these patients to determine whether any secondary neoplasia induced by the therapy and report the findings of our investigations. Melphalan (MEL) was the only drug used in single-drug chemotherapy. The incidence of chromosome abnormalities in melphalan-treated cells (25%) was higher than in the control group (17%). The incidence of structural changes was also higher (10.5%) in the MEL-treated group than in controls (6%). After treatments with combinations of drugs, the incidence of structural changes remained at the same level (11%). In the patients receiving combined treatment with MEL and radiation, the rate of structural changes increased dramatically (24%). The overall rate of chromosome aberrations in this group was also higher (50%). Combination of two or more drugs and radiation produced only 14% structural chromosome changes. The overall rate of chromosome aberrations was also low (20%) in this group. Of 111 patients studied, only 33 were alive 6 years after initiation of the study. Of the surviving patients, eight had rearranged chromosomes in the first analysis. After 5 years, new blood samples were collected from these patients and chromosome analyses showed abnormal karyotypes in all eight patients. All chromosome abnormalities in the second analysis were completely unrelated to those in the first analysis, however. Whether the chromosome changes in the second analysis were due to therapy or to other unknown factors could not be determined. Data on C-banding and the distribution of inversions indicated that 91% of the patients had C-band heteromorphisms of chromosomes 1, 91% had heteromorphisms of chromosome 9, and 69% had heteromorphisms of chromosome 16. Furthermore, inversions were observed in chromosome 1 (41% of patients), chromosome 9 (28% of patients), and chromosome 16 (5% of patients)." @default.
• W2003180819 created "2016-06-24" @default.
• W2003180819 creator A5005647428 @default.
• W2003180819 creator A5024788677 @default.
• W2003180819 creator A5042221804 @default.
• W2003180819 creator A5048156336 @default.
• W2003180819 creator A5054750064 @default.
• W2003180819 creator A5082889954 @default.
• W2003180819 date "1993-01-01" @default.
• W2003180819 modified "2023-09-24" @default.
• W2003180819 title "Cytogenetic findings in 111 ovarian cancer patients: Therapy-related chromosome aberrations and heterochromatic variants" @default.
• W2003180819 cites W1232086033 @default.
• W2003180819 cites W1602948960 @default.
• W2003180819 cites W1964309611 @default.
• W2003180819 cites W1972641136 @default.
• W2003180819 cites W1975525758 @default.
• W2003180819 cites W1979721625 @default.
• W2003180819 cites W1983049259 @default.
• W2003180819 cites W1983637546 @default.
• W2003180819 cites W1988183288 @default.
• W2003180819 cites W1990883804 @default.
• W2003180819 cites W1991494382 @default.
• W2003180819 cites W1994782266 @default.
• W2003180819 cites W1996368857 @default.
• W2003180819 cites W2007192280 @default.
• W2003180819 cites W2009619876 @default.
• W2003180819 cites W2011066731 @default.
• W2003180819 cites W2013654289 @default.
• W2003180819 cites W2014424190 @default.
• W2003180819 cites W2016758667 @default.
• W2003180819 cites W2017116002 @default.
• W2003180819 cites W2018678922 @default.
• W2003180819 cites W2019373849 @default.
• W2003180819 cites W2019428792 @default.
• W2003180819 cites W2019527633 @default.
• W2003180819 cites W2021873769 @default.
• W2003180819 cites W2022363863 @default.
• W2003180819 cites W2023527101 @default.
• W2003180819 cites W2024816595 @default.
• W2003180819 cites W2030273707 @default.
• W2003180819 cites W2031229025 @default.
• W2003180819 cites W2039276599 @default.
• W2003180819 cites W2046896128 @default.
• W2003180819 cites W2050123375 @default.
• W2003180819 cites W2051321329 @default.
• W2003180819 cites W2051409624 @default.
• W2003180819 cites W2051902571 @default.
• W2003180819 cites W2053566735 @default.
• W2003180819 cites W2057194328 @default.
• W2003180819 cites W2072404657 @default.
• W2003180819 cites W2073361796 @default.
• W2003180819 cites W2080006177 @default.
• W2003180819 cites W2081631639 @default.
• W2003180819 cites W2082114142 @default.
• W2003180819 cites W2082763393 @default.
• W2003180819 cites W2088796339 @default.
• W2003180819 cites W2092773971 @default.
• W2003180819 cites W2097062675 @default.
• W2003180819 cites W2107441498 @default.
• W2003180819 cites W2111486924 @default.
• W2003180819 cites W2158816865 @default.
• W2003180819 cites W2166263050 @default.
• W2003180819 cites W2336358779 @default.
• W2003180819 cites W2406120251 @default.
• W2003180819 cites W2409127713 @default.
• W2003180819 cites W2431341233 @default.
• W2003180819 cites W2444180111 @default.
• W2003180819 cites W2611745499 @default.
• W2003180819 cites W2886873393 @default.
• W2003180819 cites W2912910616 @default.
• W2003180819 cites W1561271362 @default.
• W2003180819 cites W2041377675 @default.
• W2003180819 doi "https://doi.org/10.1016/0165-4608(93)90056-r" @default.
• W2003180819 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8431914" @default.
• W2003180819 hasPublicationYear "1993" @default.
• W2003180819 type Work @default.
• W2003180819 sameAs 2003180819 @default.
• W2003180819 citedByCount "10" @default.
• W2003180819 countsByYear W20031808192014 @default.
• W2003180819 crossrefType "journal-article" @default.
• W2003180819 hasAuthorship W2003180819A5005647428 @default.
• W2003180819 hasAuthorship W2003180819A5024788677 @default.
• W2003180819 hasAuthorship W2003180819A5042221804 @default.
• W2003180819 hasAuthorship W2003180819A5048156336 @default.
• W2003180819 hasAuthorship W2003180819A5054750064 @default.
• W2003180819 hasAuthorship W2003180819A5082889954 @default.
• W2003180819 hasConcept C103435993 @default.
• W2003180819 hasConcept C104317684 @default.
• W2003180819 hasConcept C120665830 @default.
• W2003180819 hasConcept C121332964 @default.
• W2003180819 hasConcept C121608353 @default.
• W2003180819 hasConcept C126322002 @default.
• W2003180819 hasConcept C142724271 @default.
• W2003180819 hasConcept C143998085 @default.
• W2003180819 hasConcept C174475383 @default.
• W2003180819 hasConcept C2776694085 @default.
• W2003180819 hasConcept C2777761686 @default.
• W2003180819 hasConcept C2778684742 @default.
• W2003180819 hasConcept C2780218660 @default.
• W2003180819 hasConcept C30481170 @default.

• next